Investigation of the Production of Medical Ir-192 Used in Cancer Therapy via Particle Accelerator
Reference28 articles.
1. Ghiassi-Nejad M, Jafarizadeh M, Ahmadian-Pour MR, Ghahramani AR. Dosimetric characteristics of 192Ir sources used in interstitial brachytherapy. Applied Radiation and Isotopes. 2001;55:189-195
2. Hilgers K, Sudar S, Qaim SM. Experimental study and nuclear model calculations on the 192Os[p,n]192Ir reaction: Comparison of reactor and cyclotron production of the therapeutic radionuclide 192Ir. Applied Radiation and Isotopes. 2005;63:93-98
3. Langille G, Yang H, Zeisler SK, Hoehr C, Storr T, Andreoiu C, et al. Low energy cyclotron production and cyclometalation chemistry of iridium-192. Applied Radiation and Isotopes. 2016;115:81-86
4. Szelecsényi F, Vermeulen C, Steyn GF, Kovács Z, Aardaneh K, van der Walt TN. Excitation functions of 186,187,188,189,190,192Ir formed in proton-induced reactions on highly enriched 192Os up to 66 MeV. Nuclear Instruments and Methods B. 2010;268:3306-3314
5. Tarkanyi F, Hermanne A, Takacs S, Hilgers K, Kovalev SF, Ignatyuk AV, et al. Study of the 192Os[d,2n] reaction for production of the therapeutic radionuclide 192Ir in no-carrier added form. Applied Radiation and Isotopes. 2007;65:1215-1220